"UPMC Urology Department - UPMC Shadyside is a urology clinic located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Department of Urology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Department of Urology" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Department of Urology" are "Bladder Cancer" (1 trials), "Carcinoma, Renal Cell" (1 trials), "Prostate Cancer" (1 trials), "Renal Cell Carcinoma" (1 trials) and "Urinary Bladder Neoplasms" (1 trials). Many other conditions were trialed in "UPMC Department of Urology" in a lesser frequency.

Most popular intervention types in "UPMC Department of Urology" are "Drug" (3 trials), "Dietary Supplement" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Autologous alpha-DC1/TBVA vaccine" (1 trials), "BroccoMax®" (1 trials), "Cabozantinib" (1 trials), "Ferumoxytol intravesical administration (5 mM)" (1 trials) and "Gadobutrol intravesical administration (4mM)" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Department of Urology" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Department of Urology". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UPMC Department of Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Department of Urology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".